Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

1,118

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

August 25, 2023

Study Completion Date

September 11, 2023

Conditions
Acute Pain
Interventions
DRUG

Suzetrigine (SUZ)

Tablets for oral administration.

DRUG

HB/APAP

Capsules for oral administration.

DRUG

Placebo (matched to SUZ)

Placebo matched to SUZ for oral administration.

DRUG

Placebo (matched to HB/APAP)

Placebo matched to HB/APAP for oral administration.

Trial Locations (12)

35660

Shoals Medical Trials Inc., Sheffield

67226

Kansas Spine and Specialty Hospital, Wichita

72211

Woodland International Research Group, Little Rock

78240

Endeavor Clinical Trials, San Antonio

78258

South Texas Spine & Surgical Hospital, San Antonio

84107

JBR Clinical Research, Salt Lake City

85053

Arizona Research Center, Phoenix

91304

Alliance Research Institute, LLC, Canoga Park

91356

New Hope Research Development, Tarzana

Georgia

"Atlanta Center for Medical Research , Atlanta, GA"

Texas

"HD Research LLC , First Surgical Hospital"

"HD Research LLC , Houston Heights Hospital"

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY